𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Polyanhydride microparticles enhance dendritic cell antigen presentation and activation

✍ Scribed by Maria P. Torres; Jennifer H. Wilson-Welder; Senja K. Lopac; Yashdeep Phanse; Brenda Carrillo-Conde; Amanda E. Ramer-Tait; Bryan H. Bellaire; Michael J. Wannemuehler; Balaji Narasimhan


Publisher
Elsevier Science
Year
2011
Tongue
English
Weight
888 KB
Volume
7
Category
Article
ISSN
1742-7061

No coin nor oath required. For personal study only.

✦ Synopsis


The present study was designed to evaluate the adjuvant activity of polyanhydride microparticles prepared in the absence of additional stabilizers, excipients or immune modulators. Microparticles composed of varying ratios of either 1,6-bis(p-carboxyphenoxy)hexane (CPH) and sebacic acid or 1,8bis(p-carboxyphenoxy)-3,6-dioxaoctane and CPH were added to in vitro cultures of bone marrow-derived dendritic cells (DCs). Microparticles were efficiently and rapidly phagocytosed by DCs in the absence of opsonization and without centrifugation or agitation. Within 2 h, internalized particles were rapidly localized to an acidic, phagolysosomal compartment. By 48 h, only a minor reduction in microparticle size was observed in the phagolysosomal compartment, indicating minimal particle erosion consistent with being localized within an intracellular microenvironment favoring particle stability. Polyanhydride microparticles increased DC surface expression of major histocompatability complex class II, the costimulatory molecules CD86 and CD40, and the C-type lectin CIRE (murine DC-SIGN; CD209). In addition, microparticle stimulation of DCs also enhanced secretion of the cytokines IL-12p40 and IL-6, a phenomenon found to be dependent on polymer chemistry. DCs cultured with polyanhydride microparticles and ovalbumin induced polymer chemistry-dependent antigen-specific proliferation of both CD4 + OT-II and CD8 + OT-I T cells. These data indicate that polyanhydride particles can be tailored to take advantage of the potential plasticity of the immune response, resulting in the ability to induce immune protection against many types of pathogens.


📜 SIMILAR VOLUMES


Glycan modification of the tumor antigen
✍ Corlien A. Aarnoudse; Marieke Bax; Marta Sánchez-Hernández; Juan J. García-Valle 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 French ⚖ 291 KB

## Abstract Dendritic cells (DC) have gained much interest in the field of anticancer vaccine development because of their central function in immune regulation. However, the clinical application of __ex vivo__ cultured DC has significant disadvantages. A vaccine that targets dendritic cells __in v

Lowering the affinity between antigen an
✍ Katie Brooks; Andrew M. Knight 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 247 KB

## Abstract The B cell receptor (BCR) enables antigen‐specific B cells to bind, internalize and target antigens for processing into small peptide fragments. These epitopes are then expressed on the plasmamembrane in association with MHC class II molecules for recognition by CD4^+^ T cells. The affi

Carbohydrate-Mediated Targeting of Antig
✍ Eddie W. Adams; Daniel M. Ratner; Peter H. Seeberger; Nir Hacohen 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 507 KB

## Abstract The unique therapeutic value of dendritic cells (DCs) for the treatment of allergy, autoimmunity and transplant rejection is predicated upon our ability to selectively deliver antigens, drugs or nucleic acids to DCs in vivo. Here we describe a method for delivering whole protein antigen

Origin, maturation and antigen presentin
✍ Marina Cella; Federica Sallusto; Antonio Lanzavecchia 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 641 KB

Dendritic cells are cells specialized for antigen capture, migration and T cell stimulation. Recent advances have been made in understanding their origin, their heterogeneity, the mechanism of antigen uptake, and the signals that induce their migration and maturation into immunostimulatory antigen-p